New obesity drug AMG 133 tested in chinese adults
NCT ID NCT06352892
First seen Jan 09, 2026 · Last updated May 15, 2026 · Updated 15 times
Summary
This early-stage study tested a single dose of the experimental drug AMG 133 in 20 Chinese adults who are overweight or have obesity. The main goal was to see how the drug behaves in the body and to check for any safety issues. This is a first step to see if the drug might help manage weight in this population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Queen Mary Hospital
Hong Kong, 000, Hong Kong
Conditions
Explore the condition pages connected to this study.